News
Nov 13, 2020 | News
A landmark clinical study supported by ICAP has demonstrated that an injectable form of Pre-Exposure Prophylaxis (PrEP) is highly effective in preventing HIV acquisition in women, presenting a welcome new option to help keep women safe from the virus that causes AIDS....
Nov 13, 2020 | News
Against the backdrop of the daunting coronavirus pandemic that has reshaped the global health landscape, ICAP at Columbia University’s updated visual identity signals a newly energized organizational commitment to advancing global public health through science,...
Nov 12, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for an Nov 19 article in Columbia Public Health Magazine which reflected on the speed at which experts from all corners of the Mailman School mobilized to respond to COVID-19 as it swept the globe....
Nov 12, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for an Nov 19 article in Columbia Public Health Magazine which reflected on the speed at which experts from all corners of the Mailman School mobilized to respond to COVID-19 as it swept the globe....
Nov 12, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for an Nov 19 article in Columbia Public Health Magazine which reflected on the speed at which experts from all corners of the Mailman School mobilized to respond to COVID-19 as it swept the globe....
Nov 11, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for a Nov 10 article in City & State, New York , to discuss anticipated challenges for communities of color that will arise when an approved vaccine to treat the coronavirus is ready to be...